SDCCAG3 Antibodies

Santa Cruz Biotechnology provides a broad selection of SDCCAG3 monoclonal antibodies for research applications. SDCCAG3 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SDCCAG3, or Serologically Defined Colon Cancer Antigen 3, plays a crucial role in cellular processes, particularly in the regulation of cell division and apoptosis. SDCCAG3 expression is often associated with cancer progression, making it an important target for understanding tumor biology and developing therapeutic strategies. The study of SDCCAG3 can provide insights into the mechanisms of cancer development and potential biomarkers for diagnosis. SDCCAG3 research has revealed significant connections to various cancer pathways and cellular signaling mechanisms. Understanding SDCCAG3's role in cell division and apoptosis continues to advance cancer biology knowledge. Ongoing research with SDCCAG3 monoclonal antibodies contributes to expanding scientific understanding of cancer development and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer research and therapeutic development.